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Mycotoxin enniatin B (ENN B) is a secondary metabolism product by Fusarium fungi. 
It is a well-known antibacterial, antihelmintic, antifungal, herbicidal, and insecticidal 
compound. It has been found as a contaminant in several food commodities, partic-
ularly in cereal grains, co-occurring also with other mycotoxins. The primary mecha-
nism of action of ENN B is mainly due to its ionophoric characteristics, but the exact 
mechanism is still unclear. In the last two decades, it has been a topic of great interest 
since its potent mammalian cytotoxic activity was demonstrated in several mamma-
lian cell lines. Moreover, the co-exposure in  vitro with other mycotoxins enhances 
its toxic potential through synergic effects, depending on the concentrations tested. 
Despite its clear cytotoxic effect, European Food Safety Authority stated that acute 
exposure to ENNs, such as ENN B, does not indicate concern for human health, but 
a concern might be the chronic exposure. However, given the lack of relevant toxicity 
data, no firm conclusion could be drawn and a risk assessment was not possible. In 
fact, very few studies have been carried out in vivo and, in these studies, no adverse 
effects were observed. So, research on toxicological effects induced by ENN B is still 
on-going. Recently, some studies are dealing with new advances regarding ENN B. 
This review summarizes the information on biochemical and biological activity of 
ENN B, focusing on toxicological aspects and on the latest advances in research on 
ENN B.
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iNTRODUCTiON
Fusarium species1 are common pathogens of cereal grains, animal feeds, and food commodities 
worldwide (1). Under favorable conditions, their secondary metabolism can produce hexadep-
sipeptidic mycotoxins,2 such as enniatins (ENNs). ENNs are commonly found in several grains 
and their derived products, in fish, dried fruits, nuts, spices, cocoa, coffee products, etc. (2–7). 
1 Fusarium is a large and diverse genus of filamentous fungi of great agricultural and economic importance, containing many 
plant pathogens and mycotoxin producers.
2 Mycotoxins are secondary metabolites produced by microfungi that are capable of causing disease and death in humans and 
other animals.
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FiGURe 1 | Chemical structure of enniatins (ENNs).
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Moreover, some food processes including cooking, baking, fry-
ing, roasting, etc. do not affect their chemical structure; so, 
detoxification strategies to mitigate the risks of ENNs presence 
in foods and feed may be difficult (8, 9).
Structurally, ENNs are cyclohexadepsipeptides composed of 
alternating residues of three N-methyl amino acids, commonly 
valine, leucine, and isoleucine, and three hydroxy acids, typically 
hydroxyisovaleric acid. Several ENNs analogs (A, A1, B, B1, B2, 
B3, B4, D, E, F, and G) have been identified. Among them, the 
most prevalent ENNs reported as natural contaminants in cere-
als in Europe are ENN A, A1, B, and B1 (10). Their chemical 
structure is reported in Figure 1.
The lipophilic nature of ENNs allows them to be incorporated 
into lipid bilayers of cell membranes and creates cation selective 
pores that cause an increase in the permeability for cations, result-
ing in disturbances of the physiological cation level in the cell 
(11). Their ionophoric3 behavior seems to be related to their wide 
range of biological activity. ENNs are known to be insecticidal, 
antifungal, antibacterial, and antihelmintic (12). Moreover, they 
exerted a potent cytotoxic effect in several human and animal 
cell lines at very low micromolar range (10, 13–18). Despite the 
strong cytotoxicity in vitro, a few studies carried out in vivo did 
not show relevant toxicity (19–23).
Unlike other Fusarium mycotoxins, such as deoxynivalenol 
(DON), T-2, HT-2, fumonisins (FB), and zearalenone (ZEA), 
whose presence in food and feed has been regulated by authori-
ties, no limits have been set for ENNs, up to now. However, an 
increasing number of studies are proving their presence in sev-
eral food and feed commodities and also their toxicity (2). This 
fact may constitute a great concern for human and animal health, 
since their toxicity could be also enhanced by the presence of 
other mycotoxins at the same time. The European Commission 
asked the European Food Safety Authority (EFSA) for a scientific 
opinion on the risks to human and animal health related to the 
presence of ENNs in food and feed. EFSA concluded that acute 
exposure to ENNs does not indicate concern for human health. 
There might be a concern with respect to chronic exposure, but 
no firm conclusion could be drawn and a risk assessment was 
3 Ionophores are molecules that facilitate ion passage in or out of cell membranes.
not possible for dietary exposure to ENNs, due to the overall 
lack of toxicity data (24). At the moment, EFSA is still collecting 
occurrence data for a future risk assessment.
Among the four ENNs above-mentioned, ENN B is currently 
the most studied since it has been the most-often detected in 
unprocessed and processed grains from European countries. 
Concentrations of ENN B in grains range from a few μg/kg to 
over mg/kg (12). In a multi-mycotoxins analysis of maize silage 
in NW Spain, Dagnac et al. (25) found that ENN B was the most 
prevalent mycotoxin detected in 51% of the samples (average 
concentration: 157  µg/kg). Similar ENN B concentrations 
(195.5 ± 47.0 µg/kg) were observed in cereal samples collected 
from European and African countries (26). Svingen et al. (27) 
demonstrated the ENN B presence in all of the samples of Danish 
grain collected during the 2010 and 2011 harvests, with the 
highest value of 3,900 µg/kg detected in rye sample. A survey in 
Finland showed that ENNs were frequently detected in unpro-
cessed grains including wheat, barley, rye, and oats, and that the 
maximum concentration was found for ENN B (10,280 µg/kg) 
in a barley sample (28).
Regarding grain-based products, in pasta samples bought 
from Dutch shops, de Nijs et al. (8) found the highest incidence 
for ENN B with concentrations ranging from 7.0 to 175 µg/kg. 
Higher concentrations of ENN B (up to 1,100 µg/kg) was detected 
in pasta and baby food from Italian supermarkets by Juan et al. 
(2). Zinedine et al. (7) demonstrated that wheat couscous semo-
lina has a higher ENN B incidence and concentration (592 ng/g) 
than barley (50  ng/g) or corn (57  ng/g) semolina couscous. 
In beer samples from Germany, ENN B was the only ENN 
detected (0.9 µg/L) showing increased incidence than other myco -
toxins (29).
Therefore, the attention on ENN B toxicological aspect is still 
highly concerning, considering that its potential toxicity may be 
enhanced by co-occurrence with other ENNs or other mycotox-
ins (15, 30, 31).
Besides its ionophoric property, ENN B toxicity involves the 
inhibition of acyl-CoA: cholesterol acyl transferase (ACAT) activ-
ity4 (32) and oxidative stress5 (16). ENN B also exerts cytotoxic 
activities by inducing mitochondrial modifications and cell cycle 
disruption, finally resulting in apoptotic cell death (16, 33–35). 
Moreover, it produces adrenal endocrine toxicity (36). A recent 
study reports a potential anticancer activity (37).
The objective of this review is to compile the effects produced 
by the Fusarium mycotoxin ENN B, focusing on its biological 
properties, biochemical activity and in vitro toxicological effects 
including the latest research on ENN B, in terms of biological 
properties, biochemical activity, and toxicity.
BiOLOGiCAL PROPeRTieS OF eNN B
Enniatin B exhibits a wide array of biological activities. Several 
studies investigated the insecticidal activity of ENN B individually 
4 ACAT is an intracellular enzyme located in the endoplasmic reticulum that 
transfer fatty acyl groups from one molecule to another.
5 Oxidative stress is defined as a disturbance in the balance between the production 
of reactive oxygen species (free radicals) and antioxidant defenses.
FiGURe 2 | Scheme of the ionophore enniatin (ENN) B carrying ions by diffusing through membrane lipids.
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and in complex with other ENNs (38–42). This activity has 
been confirmed in the blowfly Calliphora erythrocephala, in 
the mosquito larvae (Aedes aegypti), in the spruce budworm 
(Choristoneura fumiferana) and against the plant-parasitic 
nematode Meloidogyne javanica (38–40). Moreover, ENN B 
partially inhibited spore germination of B. cinerea (42). However, 
no insecticidal activity of ENN B was found by Mulè et al. (43) 
against larvae of Galleria mellonella.
Enniatin B exhibits antibacterial activity against some 
pathogens of humans, such as Escherichia coli (CECT 4782), 
Enterococcus faecium (CECT 410), Salmonella enterica (CECT 
554), Shigella dysenteriae (CECT 584), Listeria monocytogenes 
(CECT935), Yersinia enterocolitica (CECT 4054), Clostridium 
perfringens (CECT 4647), Pseudomonas aeruginosa (CECT 
4628), and two strains of Staphylococcus aureus (CECT 240 and 
CECT 976) (44). Moreover, antibacterial effect of ENN B has 
been demonstrated against Mycobacterium phlei and M. paratu-
berculosis (45–47).
On the other hand, ENN B acts also as antifungal agent for 
Beauveria bassiana (CECT 20499, CECT 20191, CECT 20412) 
and Trichoderma harzianum T22 (48). A mixture of ENNs (ENN 
A, A1, B, and B1 in ratio 5:15:35:45) caused necrotic lesions 
in potato tuber tissue (49) and ENN B on knapweed leaves 
(Centaurea maculosa) when exposed with acetamido-butenolide 
(50). Combination of ENN A + ENN B showed decreased leaf 
and root development, wilting of shoots, necrosis of leaves, and 
loss of turgor (51, 52).
BiOCHeMiCAL ACTiviTY OF eNN B
ionophoric Properties
The ionophoric property of ENNs allows them to be capable of 
promoting the transport of mono- and divalent cations through 
membranes leading to toxic actions via disturbances in their 
normal physiological concentrations (1). The primary action 
is the ionophoric property, which enables ENNs to form stable 
complexes with cations, and transport them into the lipophilic 
phase (1) evoking changes in intracellular ion concentration, 
disrupting cell functions (Figure 2) (53).
The ability of the ENNs to form complexes with alkali metal 
ions and increase the cationic permeability of membranes has 
been previously documented (54, 55). In particular, cations 
transported by ENNs in liposome seems to involve a mobile car-
rier mechanism which is selective for K+ versus Na+, requiring 
two ENN molecules, and it is realized by a “sandwich” model 
(56). ENNs form both 1:1 and 2:1 ENN:cation complexes 
with alkali, alkaline earth, and various transition metal ions. 
The probability of the 3:2 conformations is much less than 
the two other conformations (57). It has been suggested that 
TABLe 1 | In vivo toxicity studies of enniatin B (ENN B).
Animal Dosage/route effects Reference
Broiler chicken 0.2 mg/kg b.w.
Bolus
Tissue bioaccumulation Fraeyman et al. (63)
Mice 5 mg/kg b.w.of ENN B
Intraperitoneal on two consecutive days
No acute damage
Tissue bioaccumulation
Rodríguez-Carrasco et al. (22)
Mice 1.25–40 mg/kg b.w. (every 8 h)
Intraperitoneal
Mice died in 2–5 days (10–40 mg/kg b.w.)
Reduction of weight
No anti-HIV activity
McKee et al. (19)
Pigs 0.05 mg/kg b.w.
Oral bolus
Absorption
ENN B > B1 > A1 > A
Devreese et al. (62)
Wistar rats Mixture of ENNs containing 1.19, 2.16, 1.03  
and 1.41 mg/kg b.w.of ENN A, A1, B, and B1
Oral
No adverse effect Escrivá et al. (23)
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electronic, inductive, or steric effects could indirectly stabilize 
the 2:1 complex. Cation selectivity was ranked as follows: 
K+ > Ca2+ ≥ Na+ > Mg2+ > Li+ (56). In addition, the transport 
efficiency appears to be related to the hydrophobic trait of the 
ENN molecules. The largest conductivity was shown for ENN B, 
followed by ENN A1 and B1 (56).
The mitochondriotoxic properties of ENNs have been dem-
onstrated in isolated rat mitochondria (11). The mitochondrial 
effects were strongly connected with the K+ ionophoric activity 
with ENNs inducing K+ uptake by mitochondria. Moreover, 
they decreased the calcium retention capacity of the mitochon-
drion matrix leading to the mitochondrial membrane potential 
(MMP) collapse via permeability transition pore (PTP) open-
ing (11, 58).
enzyme inhibitor
The inhibition of the activity of ACAT by ENN B has been 
demonstrated (32). Such inhibition could be significant in the 
treatment and prevention of atherosclerosis and hypercho-
lesterolemia. Trenin et  al. (59) showed strong hypolipidemic 
activity of ENN B in human hepatoma HepG2 cells as a result 
of the inhibition of ACAT activity, triglyceride biosynthesis, and 
diminished pool of free fatty acids in the cells.
Other Biochemical Properties
Enniatin B was the most effective inhibitor of one of the major 
multidrug efflux pumps such as Pdr5p6 in Saccharomyces cerevi-
siae at non-toxic concentrations (60). The inhibition mechanism 
is clearly different from its function as an ionophore (60). This 
ENN B property may be important for the clinical use in combi-
nation with chemotherapeutic drugs.
Enniatins interact with membrane-located ATP-binding cas-
sette (ABC) transporters7, especially with ABCB1 and ABCG2 
6 Yeast multidrug resistance protein that belongs to the family of ABC transporters. 
Pdr5p has been shown to confer resistance to a wide range of compounds and 
metal ions.
7 The ABC transporter superfamily is the largest transporter gene family. These 
proteins translocate a wide variety of substrates including sugars, amino acids, 
transporters, suggesting potential influences on bioavailability 
of xenobiotics and pharmaceuticals (61).
TOXiCiTY OF eNN B
Few toxicological studies of ENN B have been performed in vivo. 
Table 1 illustrates in vivo studies carried out with ENN B alone 
and in combination with other ENNs. In vivo toxicokinetic tri-
als using pigs demonstrated a higher bioavailability of 91% for 
ENN B (62). Interestingly, Rodríguez-Carrasco et al. (22) found 
no acute toxicity in mice after intraperitoneal administration, 
although ENN B bioaccumulation in the lipophilic tissues was 
observed. According to Fraeyman et al. (63), ENN B was read-
ily distributed to broiler chicken tissues, with mean volumes of 
distribution of 33.91 L/kg.
Comparing to in vitro studies, the number of studies in vivo 
is very low. In vitro cytotoxicity studies have been carried out for 
individual ENN B as well as for mixtures of ENNs, since mycotox-
ins, either from the same or from different fungal species, occur 
simultaneously in plant and food products (12). A scheme of 
in vitro studies on ENN B is shown in Figure 3.
In Vitro Cytotoxicity
Cytotoxicity Studies of Individual ENN B
Different cell lines and assays have been chosen to determine 
ENN B cytotoxicity. Table 2 collects the cytotoxic activity studies 
performed in several cell lines exposed to ENN B tested indi-
vidually and in complex with other ENNs (ENN A, A1, and B1) 
according to the type of cells, the toxicity endpoint, and the 
time of exposure. Data from literature show that human colon 
intestinal Caco-2 cells have been the most studied cell line when 
ENN B is applied alone (not in complex mixture), followed by 
HepG2 and CHO-K1 cells (Table 2). Exposure time goes from 
3 to 72 h and the ENN B IC50 values ranged in: (i) Caco-2 cells 
from 1.4 to >30 μM; (ii) HepG2 cells, from 0.9 to 435.9 µM; and 
(iii) CHO-K1 cells from 2.80 ± 0.16 to 11 µM. The lowest value 
metal ions, peptides, and proteins, and a large number of hydrophobic compounds 
and metabolites across extra- and intracellular membranes.
FiGURe 3 | Schema showing in vitro effects of enniatin B (ENN B).
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obtained was 0.50 of ED50 in HepG2 cells, suggesting higher 
sensitivity of this type of cells to ENN B. HT-29, MRC-5, and V7 
cell lines were also studied with different ENNs individually and 
IC50 concentrations ranged from 1.4 to 16.8 µM for HT-29, from 
0.6 to 9.8 µM for MRC-5, and from 2.5 ± 0.4 to 43 ± 20 µM for 
V7 cells, respectively.
Cytotoxicity Studies of Combined Mycotoxins 
Including ENN B
There are several studies involving mixtures of ENNs including 
ENN B, as shown in Table 2; some of these ENNs mixtures do 
not indicate exactly the percentage of each ENN. Review of the 
literature showed that the lowest IC50 value obtained with mixture 
of ENNs was for MVP-overexpressing subline cells (GLC-4/adr) 
with 1.41 ±  0.20  µM at 72  h and, the highest was obtained in 
porcine kidney cells (PK-15) with 41  µM at 72  h, followed by 
IC50 > 10 µM at 72 h for human lung cancer cells (VL8), embryonic 
fibroblast cells (WI-38), and human glioblastoma cells (T98-G).
Studies about cytotoxicity effects of ENN B in combination 
with other ENNs, and ENN B in combination with other myco-
toxins, are collected in Table 3. ENN B was tested in combination 
with ENN A, A1, and B1 by Prosperini et al. (31) in Caco-2 cells 
and by Lu et  al. (30) in CHO-K1 cells. Both studies aimed to 
investigate the type of interaction that occurs when ENNs appear 
in combination such as: synergism, antagonism, or additive effect 
by using isobologram method (70). The analysis was performed 
by testing binary and ternary combination in CHO-K1 and 
binary, ternary, and quaternary combination in Caco-2 cells. 
Prosperini et al. (31) reported a reduction of Caco-2 cell viability 
(%) in a dose-dependent manner for binary mixture tested in the 
following increasing order: ENN A +  ENN A1 (48%) =  ENN 
A1 + ENN B1 (47%) > ENN A1 + ENN B (35%) = ENN A + ENN 
B (33%) = ENN A + ENN B1 (32%) > ENN B + ENN B1 (26%). 
Similarly, tertiary and quaternary mixtures reduced cell viability 
in a dose-dependent manner with a reduction in viability of 
approximately 40%. Generally, additive cytotoxic effect was 
observed for all combinations; however, synergistic effects were 
observed for the following mixtures: ENN B + ENN A1, ENN 
B1 + ENN A1, and ENN A + ENN A1 + ENN B and, a moderate 
antagonism was produced by ENN B + ENN B1 combination.
Lu et  al. (30) found that the binary combinations ENNs 
A + B1, ENNs A1 + B, and ENNs B + B1 showed additive effects 
with all concentrations tested in CHO-K1 cells. Synergistic 
effect of combined ENNs A + A1, A + B, A1 + B1, A + A1 + B, 
A +  A1 +  B1, A +  B +  B1, and A1 +  B +  B1 at higher con-
centrations occurred. Synergism effect was observed at higher 
concentrations with binary and tertiary combinations of ENN A, 
while antagonism effects were obtained at lower concentrations 
for ENNs A + A1 + B1 and ENNs A1 + B + B1.
In addition, studies about the combination of ENNs with other 
mycotoxins have been carried out (15, 65, 71). Briefly, ENN B, 
tested with beauvericin, had additive cytotoxic effect on Human 
hematopoietic progenitors (71). Binary mixtures of ENN B 
with ZEA, DON, and nivalenol showed antagonistic and strong 
antagonistic effects on Caco-2 cell viability (65). As Fernandez-
Blanco et al. (15) reported, mixtures of ENN B + DON and ENN 
B + Alternariol (AOH) were found to be synergic, depending on 
the concentrations tested.
Oxidative Stress
One of the key players in the production of oxidative stress is 
reactive oxygen species (ROS). Moreover, intracellular ROS 
generation in the hydrophobic compartment of a cell can induce 
lipid peroxidation (LPO).8 ROS generation and LPO have been 
observed in mammalian cells exposed to ENN B (10, 16). In 
addition, Ivanova et  al. (10) found that ENN B-induced ROS 
production after 3 h exposure to ENN B in Caco-2 cells that were 
generated downstream the ENN B-induced cytotoxic events by 
the mitochondria. On the contrary, Dornetshuber (68) dem-
onstrated that genotoxic potential and cytotoxicity of ENNs is 
independent of ROS generation. Further research is needed in 
this area.
8 Lipid peroxidation can be described generally as a process under which oxidants 
such as free radicals attack lipids containing carbon-carbon double bond(s), 
especially polyunsaturated fatty acids.
TABLe 2 | In vitro cytotoxicity studies on enniatin B determined by different toxicity endpoint, time of exposure and cell types.
Cell lines Cell types Parameter exposure 
time (h)
iC50 (μM) Reference
A427 Human lung cancer MTT 72 ENNmix: 1.61 ± 0.14 Dornetshuber et al. (33)
A549 ENNmix: 4.08 ± 1.04
Balb 3T3 Mouse embryo fibroblast ATP production 24 ED50: 8.4 ± 0.76 Jonsson et al. (13)
BrdU ELISA ED50: 4.24 ± 0.06
Apoptosis induction ED50: 11
Caco-2 Human colon adenocarcinoma NR 3, 24 10.0 ± 3.8–2.1 ± 0.4 Ivanova et al. (10)
24, 48, 72 >15–1.4 ± 0.2 Prosperini et al. (16)
24, 48 >30 Meca et al. (44)
24, 48 No IC50 value obtained Meca et al. (64)
72 ENNmix: 1.99 ± 0.09 Dornetshuber et al. (33)
24, 48, 72 >15–11.7 ± 2.4 Prosperini et al. (31)
WST-1 24 6.3 Vejdovszky et al. (65)
CHO-K1 Chinese hamster ovary MTT 24, 48, 72 11.0 ± 2.65–2.80 ± 0.16 Lu et al. (30)
24 11.0 ± 2.65 Lombardi et al. (66)
C6 Rat glioma MTT 3, 24 ENNmix: 2.5–10 Wätjen et al. (34)
GLC-4 Breast adenocarcinoma MTT 72 ENNmix: 2.40 ± 1.53 Dornetshuber et al. (33, 61)
GLC-4/adr MVP-overexpressing subline MTT 72 ENNmix: 1.41 ± 0.83 Dornetshuber et al. (61)
GBL1 Human Glioblastoma MTT 72 ENNmix: 2.65 ± 0.30 Dornetshuber et al. (33)
GBL2 ENNmix: 2.29 ± 0.05
GBL3 ENNmix: 2.55 ± 0.14
GBL4 ENNmix: 2.33 ± 0.30
H-4IIE Rat hepatocarcinoma MTT 3, 24 ENN A1, B and B1: 1–1.5 Wätjen et al. (34)
Hep G2 Human hepatocarcinoma MTT 24, 48 No IC50 value obtained Meca et al. (64)
3, 24 ENN A1, B and B1: 10 Wätjen et al. (34)
Alamar Blue BrdU 24 206.7–435.9 Ivanova et al. (18)
0.9–1.1
ATP production 24 ED50: 2.9 ± 0.7 Jonsson et al. (13)
BrdU ELISA ED50: 0.50 ± 0.09
Qaudroprobe multiparametric 
liver toxicity assaya
24, 72 0.9b Svingen et al. (27)
HL60 Promyelocityc leukemia carcinoma MTT 72 ENNmix: 1.74 ± 0.20 Dornetshuber et al. (33, 61)
HL60/vinc ABCB1-overexpressing subline MTT 72 ENNmix: 2.40 ± 0.14 Dornetshuber et al. (61)
HL60/adr ABCC1-overexpressing subline MTT 72 ENNmix: 2.1 ± 0.12 Dornetshuber et al. (61)
HT-29 Human colon adenocarcinoma MTT 24, 48 2.8 ± 0.9 Meca et al. (64)
HUVEC Human endothelial MTT 72 ENNmix: 7.89 ± 0.21 Dornetshuber et al. (33)
KB-3-1 Epidermal carcinoma MTT 72 ENNmix: 1.95–0.12 Dornetshuber et al. (33, 61)
KBC-1 ABCB1-overexpressing subline MTT 72 ENNmix: 1.77 ± 0.04 Dornetshuber et al. (61)
MDA-MB-231 Alveolar epithelial MTT 72 ENNmix: 2.36 ± 1.57 Dornetshuber et al. (33, 61)
MDA-MB-231/adr ABCG2-overexpressing subline MTT 72 ENNmix: 3.18 ± 1.70 Dornetshuber et al. (61)
MGC Human glioblastoma MTT 72 ENNmix: 3.04 ± 0.58 Dornetshuber et al. (33)
MRC-5 Fibroblast-like fetal lung Alamar Blue BrdU 24 1.9–9.8 Ivanova et al. (18)
1.9–3.6
OS 9 Human osteosarcoma MTT 72 ENNmix: 3.55 ± 0.77 Dornetshuber et al. (33)
OS 10 ENNmix: 2.10 ± 0.15
Porcine kidney 
cells-15
Porcine Kidney MTT 72 ENNmix: 41 Uhlig et al. (67)
RAW 264.7 Murine macrophage Alamar blue 24 2.6 Gammelsrud et al. (35)
NR 4.7
SAOS Human osteosarcoma MTT 72 ENNmix: 2.13 ± 0.07 Dornetshuber et al. (33)
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(Continued)
TABLe 3 | Combinedeffect of ENN B tested in combination with other mycotoxins by in vitro methods.
Cell line Mycotoxin combination effect interaction (in the combination) Reference
Caco-2 ENN A + A1 Cytotoxicity Add Prosperini et al. (31)
ENN A + B
ENN A + B1
ENN B + B1
ENN A + A1 + B1
ENN A + B + B1
ENN A1 + B + B1
ENN A + A1 + B + B1
ENN A1 + B1 Syn
ENN A1 + B
ENN A + A1 + B
ENN B + B1 Ant
ENN B + ZEA Cytotoxicity Ant Vejdovszky et al. (65)
ENN B + DON
ENN B + NIV Strong
Antagonism 
ENN B + AOH Syn Fernandez-Blanco et al. (15)
ENN B + DON Add/Syn
ENN B + AOH + DON Add/Syn
CHO-K1 ENN A + B1 Cytotoxicity Add Lu et al. (30)
ENN A1 + B
ENN B + B1
ENN A + A1 Syn
ENN A + B
ENN A1 + B1
ENN A + A1 + B
ENN A + B + B1
ENN A + A1 + B1 Ant
ENN A1 + B + B1
Human hematopoietic progenitors BEA + ENN B Myelotoxicity Add Ficheux et al. (71)
AOH, alternariol; DON, deoxynivalenol; ZEA, zearalenone; NIV, nivalenol; ENN, Enniatin.
Cell lines Cell types Parameter exposure 
time (h)
iC50 (μM) Reference
SW1537 Small cell lung carcinoma MTT 72 ENNmix: 2.16 ± 0.12 Dornetshuber et al. (61)
SW1537/2R160 ABCB1-overexpressing subline MTT 72 ENNmix: 2.69 ± 0.60 Dornetshuber et al. (61)
SW480 Small cell lung carcinoma MTT 72 ENNmix: 4.00 ± 1.12 Dornetshuber et al. (33)
T98-G Human glioblastoma MTT 72 ENNmix: >10 Dornetshuber et al. (33)
U373 Human glioblastoma MTT 72 ENNmix: 4.88 ± 0.09 Dornetshuber et al. (33)
U2-OS Osteosarcoma MTT 72 ENNmix: 1.77 ± 0.24 Dornetshuber et al. (33)
V79 Chinese hamster fibroblast NR 48 4.4 Dornetshuber et al. (68)
Alamar blue 24–48 34 ± 20–2.5 ± 0.4 Föllmann et al. (69)
NR 36 ± 16–4 ± 1.5
43 ± 20–3.9 ± 3.9Protein content (BCA)
VM8 Melanoma MTT 72 ENNmix: 3.19 ± 0.85 Dornetshuber et al. (33)
VM18 ENNmix: 2.67 ± 0.08
VM22 ENNmix: 1.75 ± 0.15
VM33 ENNmix: 9.65 ± 0.13
VM25 ENNmix: 2.72 ± 0.11
VL8 Human lung cancer MTT 72 ENNmix: >10 Dornetshuber et al. (33)
WI-38 Embryonic fibroblast MTT 72 ENNmix: >10 Dornetshuber et al. (33)
IC50 = inhibitory concentration at which 50% of enzyme activity is inhibited; ED50 = effective dose at which 50% of cells are affected.
aUsingfour fluorophore probes, six cytotoxicity-associated parameters were analyzed simultaneously: nuclear count and size, plasma membrane integrity, lysosomal activity, 
mitochondrial membrane potential, and mitochondrial area.
bThe concentration that deviated significantly from the control cell responses.
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impairment of Cell Cycle Distribution
Cell cycle is the entire process by which a cell undergoes cell divi-
sion. Cell cycle phases are: the G1 phase, where cells are preparing 
for DNA, RNA, and protein synthesis, the S phase where DNA is 
synthesized, the G2 phase, where cells are preparing for mitosis, 
and finally the M phase (mitosis) where two daughter cells are 
generated. Cells can remain in a quiescent phase (G0 phase) and 
they need growth factors to enter the G1 phase.
It has been demonstrated that mycotoxins can disturb the nor-
mal cell cycle distribution due to their anti-proliferative effects on 
several cell types, with an accumulation of cells in one or more 
phases of the cell cycle (14)9. Juan-García et al. (72) observed that 
in HepG2, ENN B provoked a higher percentage of cells arrested 
at G0/G1 at 48 h than ENN A. A similar behavior was reported by 
Gammelsrud et al. (35) on murine monocytes macrophage RAW 
267.4 cells: an increase in percentage of cells in G0/G1 phase 
when treated during 24 h with ENN B (from 1.25 to 10 µM). In 
general, cell accumulation during cell cycle in any phase after a 
treatment indicates an anti-proliferative activity of the compound 
or compounds used. The same behavior was observed in several 
human cancer cell lines by Dornetshuber et al. (33).
In Caco-2 cells, as described by Prosperini et al. (16), ENN 
B (3 µM) induced an arrest of the cell cycle in G2/M phase after 
72 h of exposure with a significant increase in G2/M cell number 
compared to the control. A decrease of the S phase cell population 
and an increase in SubG0/G1 were also observed.
A noticeable increase of cells in the G2/M phase in Caco-2 cells after 
ENN B treatment was also observed by Ivanova et al. (10) confirming 
the impairment of mitosis. This type of arrest has been described as 
a possible consequence of external stimuli leading to apoptosis by 
activation of the caspase pathway or to non-apoptotic mitotic death.
Apoptosis/Necrosis
Enniatin B alone and in mixture with other ENNs induced apop-
tosis in several cell lines with nuclear fragmentation and apop-
totic body formation (13, 14, 16, 33–35, 68, 69, 72). Moreover, the 
necrotic cell death has been also reported (10, 16, 35). Apoptotic 
effect and necrotic10 pathway was observed in Caco-2 cells after 
48 h of exposure to ENN B (10, 16).
Juan-García et al. (72) found that both ENN B and ENN A 
(1.5 and 3.0 µM) caused apoptosis in HepG2 cells, after 48 h of 
exposure, identifying ENN B more toxic than ENN A. Necrotic 
pathway was not observed. Similar results were obtained in 
mouse embryo fibroblast (Balb 3T3) cells (from 11 to 45  µM) 
(13), in murine monocyte (RAW 267.4) macrophages (35) and in 
human adrenocortical carcinoma cell line H295R (36).
9 The natural cell cycle includes a number of checkpoints that allow the cell to deter-
mine whether to proceed with division or stop. These halts can also be induced by 
external factors like chemicals. Research on cell cycle arrest provides important 
information about how cells regulate themselves and what happens when these 
processes go wrong.
10 Two different ways of cells can die are apoptosis or necrosis. Apoptosis is described 
as an active, programmed process of autonomous cellular dismantling that avoids 
eliciting inflammation. Necrosis has been characterized as passive, accidental cell 
death resulting from environmental perturbations with uncontrolled release of 
inflammatory cellular contents.
MMP Disruption
Mitochondria have been recognized for their role in mediating 
physiological processes and their involvement in signal trans-
duction and regulation of cell proliferation and differentiation. 
They are involved also in cell death regulation, i.e., necrosis and 
apoptosis. Due to this role, mitochondria are vulnerable to the 
toxic effects of xenobiotics that interfere in cellular energy pro-
duction. Apoptosis and necrosis induced cell death by cytotoxic 
agents involve similar metabolic disturbances and above all, 
mitochondrial permeability transition (MPT). Mitochondrial 
events of apoptosis and necrosis involve opening of a pore in the 
inner mitochondrial membrane, referred as mitochondrial PTP 
(MPTP) and the consequent dissipation of membrane potential 
(73). The dissipation of the MMP results from the unequal dis-
tribution of ions (mainly protons) on the inner mitochondrial 
membrane. The MMP disruption suggests that the proton-
moving force and/or the inner membrane permeability has been 
affected during cell damage. The dissipation of MMP is a general 
feature of both cell death types (16).
Measurements of MMP are carried out by using lipophylic 
dyes, which pass through cell membranes and accumulate 
according to their charge. The alteration of fluorescent intensity 
can be determined by flow cytometry. Among these dyes, the 
tetramethylrhodamine methyl ester (TMRM), coupled with the 
carbocyanine monomer nucleic acid (To-Pro-3), has been used 
to determine the mitochondrial starting depolarization and cells 
progressing to death through apoptosis (72).
The disruption of MMP has been demonstrated in KB-3-1 
cells exposed to ENNs mixture (33), and to ENN B in Caco-2 
and HepG2 cells (10, 16, 72). The exact mechanism by which 
pro-oxidant mycotoxins induced pore opening is still not fully 
understood. At least two molecular sites of the complex contribute 
to this effect. The first site is a redox sensitive membrane dithiol 
group that can be oxidized by ROS (produced by mycotoxins), the 
second one remains undetermined.
Mitochondrial membrane potential was measured also by 
Svingen et al. (27) by the Hep-G2 quadroprobe multi-parametric 
liver toxicity assay. The strongest effect was seen for plasma mem-
brane integrity, with concomitant effects on mitochondrial area/
mass and mitochondrial potential, confirming the involvement of 
mitochondria in ENNs toxicity (11).
estrogenic Activity
Recently, an investigation to evaluate possible endocrine dis-
ruptor effects11 of ENN B was conducted by Kalayou et al. (36) 
demonstrating that in the human adrenocortical carcinoma cell 
line H295R, ENN B (10  µM) was able to reduce progesterone, 
testosterone, and cortisol production at a non-cytotoxic concen-
tration. Higher concentrations (>10 μM) reduced both estradiol 
and testosterone levels in Leydig cells (36). Additional research 
11 Chemicals that mimic or antagonize the in vitro and/or in vivo actions of naturally 
occurring estrogens are typically defined as having estrogenic activity or anti-
estrogenic activity. Effects on estrogen signaling represent the most common and 
best studied endocrine disruptor activity.
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should be conducted using ovarian steroid producing cells such 
as granulosa cells.
Genotoxicity
Genotoxicity12 seems to be not involved in ENN B induction of 
cell death. As reported by Follmann et al. (69), ENN B, despite 
its high cytotoxic potential, did not induce any DNA damage 
by the alkaline Comet Assay in V79 cells after concentrations 
ranging from 1 to 100 µM. Results are in accordance with those 
obtained by Gammelsrud et al. (35) and Prosperini et al. (16) in 
Caco-2 cells.
eMeRGiNG FiNDiNGS OF eNN B
Some researchers are underlying the anticancer potential of 
ENN B (33, 34, 61, 68). Apoptosis with the involvement of p53 
and p21 genes was found by Dornetshuber et  al. (33), which 
tested a mixture of ENNs against several human cancer cells, 
promoting ENNs as anticancer drugs, according also to Wätjen 
et al. (34) and Dornetshuber-Fleiss et al. (37). In these surveys, 
ENNs caused caspase 3/7 activation in hepatoma H4IIE cells and 
caspase-7 activation in the KB-3-1 cell line, respectively, as well 
as nuclear fragmentation.
Enniatin B is capable of resisting expulsion by the ABC trans-
porters, and also naturally targets tumor cells more specifically 
than other chemotherapeutic agents. The action is synergic with 
the clinically approved multi-kinase inhibitor sorafenib (Sora) 
showing profound synergistic in  vitro and in  vivo anticancer 
effects against cervical cancer (37).
CONCLUDiNG ReMARKS
Mycotoxins constitute a serious health concern both for animals 
and for humans, besides economic problems. Productive and 
nutritive values of food and feed can be compromised by mold 
12 Genotoxicity is defined as the destructive effect on a cell’s genetic material (DNA 
and RNA) affecting its integrity.
and mycotoxin contamination, and toxicological risk derived 
by ingestion is constantly under Authorities control. Regarding 
ENNs, a risk assessment is still not available, despite its clear 
toxicity in vitro and its presence in food and feed.
Indeed, several in  vitro and in  vivo studies have revealed 
that ENN B interacts with primary target molecules, induce 
signaling pathways and effector mechanisms, affects the bio-
logical response of cell defenses, promotes cell damage, produces 
potential interactions between food contaminants (particularly 
other mycotoxins) leading to abnormally high response, and 
other molecular events underlying ENN B toxicity. Nevertheless, 
regulatory limits have not yet been defined, due to a lack of 
complete toxicity data.
However, in the last decade, novel findings about a potential 
therapeutic action of ENNB have been proven. These promising 
findings introduce a new aspect of this toxic compound. Future 
research focused on elucidating the toxic mechanism of ENN 
B as well as its anticancer activity could better clarify the real 
potential of ENN B. These research findings could contribute 
to establish emerging therapeutic strategy to chronic health 
problems.
This review wanted to collect all available data regarding 
toxicological aspect and emerging findings on ENN B in order to 
underlying the need to continue to study toxic/emerging effects 
of this compound to finally protect and improve both animal and 
human well-being.
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